Repertoire Genesis Inc. (Headquarters: Ibaraki, Osaka) entered into a world-wide, non-exclusive collaboration agreement with QIAGEN Manchester Limited. (Headquarters: Manchester, United Kingdom) on companion diagnostics development and commercialization for cancer immunotherapy.

View original content:Press Release